DNAPrint genomics Ticker Symbol Changing to 'DNAG' - Biotech News
DNAPrint genomics DNAGDNAPrint genomics Ticker Symbol Changing to 'DNAG'
Monday July 11, 1:02 pm ET
DNAPrint genomics, Inc. (OTC Bulletin Board: DNAP - News) today announced that commencing with the opening of the market on Tuesday, July 12, 2005, the Company's Common Stock will begin trading on the Over-the-Counter Bulletin Board under the symbol "DNAG."
The change of the symbol is the result of a stock consolidation approved by shareholders and the Board of Directors that also becomes effective the same day.
About DNAPrint genomics, Inc.
DNAPrint genomics, Inc. ( http://www.dnaprint.com ) is a developer of genomics-based products and services focused on drug development, pharmacogenomic diagnostic tests, forensics technology and consumer genetic tests. The Company's first theranostic product (drug/test combination) is PT- 401, a "Super EPO" (erythropoietin) dimer protein drug for treatment of anemia in renal dialysis patients (end stage renal disease). Currently in pre- clinical development, PT-401 will be targeted to patients with a genetic profile indicating their propensity to have the best clinical response.
--------------------------------------------------------------------------------
Source: DNAPrint genomics
Arizona Biotech
0 Comments:
Post a Comment
<< Home